« Back to Record
Sonnenblick, A., Kroep, J., Cufer, T., Simon, S., Salman, P., Toi, M., Harris, L., Gralow, J., Keane, M., Moreno-Aspitia, A., Piccart-Gebhart, M., Agbor‑Tarh, D., de Azambuja, E., Bradbury, I., Di Cosimo, S., Abdel Azim, H. H., Fumagalli, D., Sarp, S., Wolff, A. A. C. A., & Andersson, M. (2017). Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: Analysis from the ALTTO phase III randomized trial. Journal of clinical oncology, 35(13), 1421-1429. doi:10.1200/JCO.2016.69.7722
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253211



